Tectonic Therapeutic, Inc.
TECX
$34.91
$0.932.74%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -4.04% | 24.25% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.29% | 26.89% | |||
| Operating Income | 11.29% | -26.89% | |||
| Income Before Tax | 12.02% | -33.04% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 11.71% | -31.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.71% | -31.29% | |||
| EBIT | 11.29% | -26.89% | |||
| EBITDA | 11.35% | -27.45% | |||
| EPS Basic | 12.62% | -30.93% | |||
| Normalized Basic EPS | 12.92% | -32.68% | |||
| EPS Diluted | 12.62% | -30.93% | |||
| Normalized Diluted EPS | 12.92% | -32.68% | |||
| Average Basic Shares Outstanding | 1.04% | 0.27% | |||
| Average Diluted Shares Outstanding | 1.04% | 0.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||